The prime purpose of this clinical trial was to examine the clinical quality and retention rate of resin composite in connection with two recently developed acetone-based primer adhesives in Class V lesions according to ADA Clinical Protocol Guidelines for Dentin and Enamel Adhesive Materials. All cavities were nonretentive and predominantly in dentin (mixed Class V lesions). Total bonding was not limited either by sub-base or by base materials. All the trial restorations were placed under rubber dam. Group 1 (Version 16-135-1) and group 2 (Version 17-17-1) consisted of 42 patients with 46 trials and 38 patients with 43 fillings, respectively. The mean follow-up period and the recall response at the end of the study of group 1 were 22.8 months and 92.9% and of group 2 were 22.4 months and 94.7%. The trial restorations of both groups maintained their predominantly rated USPHS-Code Alpha level within the follow-up period. The cumulative failure rate of two trials in group 1 and four in group 2 determined a failure percentage of 4.4% and 9.3%, respectively, which is within the ADA-18 month limit of <10% Charlie. The Version KL 16-135-1 came into the market as Prime & Bond(R) 2.1, and the other one turned out to be Dyract Adhesive(R) PSA, which was primarily introduced as a single-component adhesive for compomer restorative Dyract(R) (Dentsply DeTrey, Germany).